Even if the lazy cash doesn't find an opportunity for expansion it should be at least a 10 bragger. All its Chinese company piers are trading at more than 8 X earnings.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come